Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery

European Georges Pompidou Hospital

Status: Completed

Conditions: Fibrosis, Liver; Obesity; Steatosis

Treatments: Device: Evaluation of the Diagnostic of Hepatic Fibrosis With the XL Probe of the Fibroscan Versus Biopsies in Severe Obese Patients Candidates to Bariatric Surgery

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03548597

B047

Details and patient eligibility

About

Background:

The XL probe of FibroScan was recently developed to realize liver stiffness measurements (LSM) in overweight patients.

Severe obese patients have a high prevalence of liver injuries and could benefit of liver evaluation prior to bariatric surgery.

Objectives:

Assess the FibroScan applicability, reliability and diagnostic performances in severe obese patients' candidates for bariatric surgery.

Enrollment: 132 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Severe obese patients candidate to bariatric surgery with no history of liver disease have a large prevalence of liver lesions.